Remission in Rheumatoid Arthritis in the Asian-Pacific Region

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03365856

Enrollment

1500

Registered

2017-12-07

Start date

2018-01-01

Completion date

2018-06-01

Last updated

2017-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

This study is the multi-center, open and cross-sectional study of RA remission in Asia Pacific region. The objectives is to explore remission rate of RA patients in different countries in the Asian-Pacific area using different criteria of remission (DAS28, CDAI, SDAI, ACR/EULA remission criteria, RAPID3 and Clin28) and investigate the associated factors of remission in RA patients.

Interventions

OTHERobservational study

as clinical practice

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* RA patients fulfilled the American College of Rheumatology 1987 criteria or the 2010 ACR/EULAR classification criteria. * Patients aged \> 18 years.

Exclusion criteria

* No

Design outcomes

Primary

Measure	Time frame	Description
remission rate of RA patients in different countries in the Asian-Pacific area	12-24 months	according to the different criteria of clinical remission in RA patients

Contacts

Primary ContactRu Li, Dr.

doctorliru123@163.com86-18611616251

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026